应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02493 迈威生物-B
休市中 11-20 16:08:27
17.030
-0.390
-2.24%
最高
17.390
最低
16.730
成交量
16.18万
今开
17.000
昨收
17.420
日振幅
3.79%
总市值
76.12亿
流通市值
8.03亿
总股本
4.47亿
成交额
275.77万
换手率
0.34%
流通股本
4,713万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
11月20日迈威生物跌6.38%,中航优选领航混合发起A基金重仓该股
证券之星 · 11-20 16:58
11月20日迈威生物跌6.38%,中航优选领航混合发起A基金重仓该股
迈威生物(688062)11月13日主力资金净卖出2312.99万元
证券之星 · 11-14
迈威生物(688062)11月13日主力资金净卖出2312.99万元
11月13日迈威生物跌5.58%,中航优选领航混合发起A基金重仓该股
证券之星 · 11-13
11月13日迈威生物跌5.58%,中航优选领航混合发起A基金重仓该股
迈威生物(688062)11月5日主力资金净卖出202.65万元
证券之星 · 11-06
迈威生物(688062)11月5日主力资金净卖出202.65万元
迈威生物-B更新10月股份变动月报表,股本维持不变
公告速递 · 11-05
迈威生物-B更新10月股份变动月报表,股本维持不变
11月4日迈威生物涨5.49%,中航优选领航混合发起A基金重仓该股
证券之星 · 11-04
11月4日迈威生物涨5.49%,中航优选领航混合发起A基金重仓该股
迈威生物涨5.49%,中邮证券一个月前给出“买入”评级
证券之星 · 11-04
迈威生物涨5.49%,中邮证券一个月前给出“买入”评级
股市必读:迈威生物新发布《迈威生物关于召开2026年第三季度业绩说明会的公告》
证券之星 · 11-02
股市必读:迈威生物新发布《迈威生物关于召开2026年第三季度业绩说明会的公告》
10月30日迈威生物跌6.18%,中航优选领航混合发起A基金重仓该股
证券之星 · 10-30
10月30日迈威生物跌6.18%,中航优选领航混合发起A基金重仓该股
迈威生物-B(02493)定于11月9日举办2026年第三季度业绩说明会
公告速递 · 10-29
迈威生物-B(02493)定于11月9日举办2026年第三季度业绩说明会
迈威生物:关于召开2026年第三季度业绩说明会的公告
同花顺 · 10-29
迈威生物:关于召开2026年第三季度业绩说明会的公告
迈威生物9月30日股东户数1.86万户,较上期增加0.54%
同花顺 · 10-29
迈威生物9月30日股东户数1.86万户,较上期增加0.54%
迈威生物-B(02493)前三季度实现营业收入约6.21亿元 同比增长9.77%
智通财经 · 10-28
迈威生物-B(02493)前三季度实现营业收入约6.21亿元 同比增长9.77%
迈威生物-B(02493.HK)前三季度实现营业收入约6.21亿元 同比增长9.77%
智通财经 · 10-28
迈威生物-B(02493.HK)前三季度实现营业收入约6.21亿元 同比增长9.77%
迈威生物2026年前三季度净亏损6.78亿元
同花顺 · 10-28
迈威生物2026年前三季度净亏损6.78亿元
迈威生物:第三季度亏损扩大至1.57亿元 营收同比降33.6%
财中社 · 10-28
迈威生物:第三季度亏损扩大至1.57亿元 营收同比降33.6%
迈威生物(688062)10月23日主力资金净卖出680.54万元
证券之星 · 10-24
迈威生物(688062)10月23日主力资金净卖出680.54万元
港股异动 | 迈威生物-B(02493.HK)涨近3% 将于ESMO 2026大会上以口头报告形式报告9MW2821临床数据
智通财经 · 10-23
港股异动 | 迈威生物-B(02493.HK)涨近3% 将于ESMO 2026大会上以口头报告形式报告9MW2821临床数据
迈威生物将在2026年ESMO口头报告9MW2821三阴性乳腺癌II期临床数据
同花顺 · 10-19
迈威生物将在2026年ESMO口头报告9MW2821三阴性乳腺癌II期临床数据
迈威生物-B拟在2026年ESMO大会口头报告9MW2821治疗三阴性乳腺癌II期临床数据
公告速递 · 10-19
迈威生物-B拟在2026年ESMO大会口头报告9MW2821治疗三阴性乳腺癌II期临床数据
加载更多
公司概况
公司名称:
迈威生物-B
所属市场:
SEHK
上市日期:
--
主营业务:
公司是一家全产业链布局的创新型生物制药公司,始终秉承“让创新从梦想变成现实”的愿景,践行“探索生命,惠及健康”的使命,通过源头创新,为患者提供疗效更好、可及性更强的生物创新药,满足全球未被满足的临床需求。公司主营业务为研发、生产以及销售创新型药物和生物类似药。公司主要产品为抗体、ADC药物和重组蛋白、小分子化学药等药物。公司荣誉:上海产业人才队伍建设工作“优秀案例奖”、澳洲会计师公会“认可雇主”、星耀榜“2021中国生物创新药最具成长性年度大奖”、中国医药人才品牌榜总榜及最具竞争力品牌等。
发行价格:
--
{"stockData":{"symbol":"02493","market":"HK","secType":"STK","nameCN":"迈威生物-B","latestPrice":17.03,"timestamp":1795162107620,"preClose":17.42,"halted":0,"volume":161800,"delay":0,"changeRate":-0.022388059701492567,"floatShares":47130200,"shares":447000000,"eps":-2.43,"marketStatus":"休市中","change":-0.39,"latestTime":"11-20 16:08:27","open":17,"high":17.39,"low":16.73,"amount":2757732,"amplitude":0.037887,"askPrice":17.03,"askSize":4800,"bidPrice":16.7,"bidSize":400,"shortable":0,"etf":0,"ttmEps":-2.738,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1795397400000},"marketStatusCode":7,"adr":0,"listingDate":1777305600000,"exchange":"SEHK","adjPreClose":17.42,"openAndCloseTimeList":[[1795138200000,1795147200000],[1795150800000,1795161600000]],"volumeRatio":0.9288174509922349,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688062","market":"SH","secType":"STK","nameCN":"迈威生物-U","latestPrice":17.02,"timestamp":1795158000000,"preClose":18.18,"halted":0,"volume":7267400,"delay":0,"premium":"-14.69"}},"requestUrl":"/m/hq/s/02493","defaultTab":"news","newsList":[{"id":"2684320511","title":"11月20日迈威生物跌6.38%,中航优选领航混合发起A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2684320511","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684320511?lang=zh_cn&edition=full","pubTime":"2026-11-20 16:58","pubTimestamp":1795165126,"startTime":"0","endTime":"0","summary":"证券之星消息,11月20日迈威生物跌6.38%创60日新低,收盘报17.02元,换手率1.82%,成交量7.27万手,成交额1.26亿元。根据2026基金Q3季报公募基金重仓股数据,重仓该股的公募基金共11家,其中持有数量最多的公募基金为中航基金的中航优选领航混合发起A。中航优选领航混合发起A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026112000029475.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02493","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683375681","title":"迈威生物(688062)11月13日主力资金净卖出2312.99万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2683375681","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683375681?lang=zh_cn&edition=full","pubTime":"2026-11-14 08:30","pubTimestamp":1794616209,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月13日收盘,迈威生物报收于20.3元,下跌5.58%,换手率2.08%,成交量8.32万手,成交额1.73亿元。近5日资金流向一览见下表:迈威生物融资融券信息显示,融资方面,当日融资买入825.28万元,融资偿还686.73万元,融资净买入138.55万元,连续3日净买入累计893.04万元。迈威生物主营业务:研发、生产以及销售创新型药物和生物类似药,以高效创新研发和产业化能力为支撑,通过治疗用生物制品的市场推广和销售获得商业利润。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111400007627.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02493","688062","BK1161","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683857346","title":"11月13日迈威生物跌5.58%,中航优选领航混合发起A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2683857346","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683857346?lang=zh_cn&edition=full","pubTime":"2026-11-13 16:43","pubTimestamp":1794559421,"startTime":"0","endTime":"0","summary":"证券之星消息,11月13日迈威生物跌5.58%,收盘报20.3元,换手率2.08%,成交量8.32万手,成交额1.73亿元。根据2026基金Q3季报公募基金重仓股数据,重仓该股的公募基金共11家,其中持有数量最多的公募基金为中航基金的中航优选领航混合发起A。中航优选领航混合发起A目前规模为0.65亿元,最新净值1.4458,较上一交易日下跌0.97%,近一年下跌21.6%。中航优选领航混合发起A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111300029994.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02493","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681817308","title":"迈威生物(688062)11月5日主力资金净卖出202.65万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2681817308","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681817308?lang=zh_cn&edition=full","pubTime":"2026-11-06 08:20","pubTimestamp":1793924411,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月5日收盘,迈威生物报收于22.67元,上涨5.29%,换手率2.13%,成交量8.5万手,成交额1.91亿元。近5日资金流向一览见下表:迈威生物融资融券信息显示,融资方面,当日融资买入1283.68万元,融资偿还1061.09万元,融资净买入222.59万元。迈威生物主营业务:研发、生产以及销售创新型药物和生物类似药,以高效创新研发和产业化能力为支撑,通过治疗用生物制品的市场推广和销售获得商业利润。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600008374.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","688062","BK0239","02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132034064","title":"迈威生物-B更新10月股份变动月报表,股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1132034064","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132034064?lang=zh_cn&edition=full","pubTime":"2026-11-05 16:42","pubTimestamp":1793868147,"startTime":"0","endTime":"0","summary":"迈威(上海)生物科技股份有限公司于2026年11月5日披露10月股份变动月报表,报告期为截至2026年10月31日止一个月。公告显示,公司在香港上市的H股数量为47,130,200股,与上月持平;A股注册股份总数为399,600,000股,同样维持不变。公司截至本月底的注册股本总额为人民币446,730,200元。报告期内,迈威生物-B未进行新增发行、股份购回、注销或其他形式变动,H股与A股实收资本无变化。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680035702","title":"11月4日迈威生物涨5.49%,中航优选领航混合发起A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2680035702","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680035702?lang=zh_cn&edition=full","pubTime":"2026-11-04 17:06","pubTimestamp":1793783203,"startTime":"0","endTime":"0","summary":"证券之星消息,11月4日迈威生物涨5.49%,收盘报21.53元,换手率2.45%,成交量9.8万手,成交额2.05亿元。根据2026基金Q3季报公募基金重仓股数据,重仓该股的公募基金共11家,其中持有数量最多的公募基金为中航基金的中航优选领航混合发起A。中航优选领航混合发起A目前规模为0.65亿元,最新净值1.3389,较上一交易日下跌3.3%,近一年下跌21.6%。中航优选领航混合发起A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400032062.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680303688","title":"迈威生物涨5.49%,中邮证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2680303688","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680303688?lang=zh_cn&edition=full","pubTime":"2026-11-04 17:06","pubTimestamp":1793783192,"startTime":"0","endTime":"0","summary":"今日迈威生物(688062)涨5.49%,收盘报21.53元。2026年9月10日,中邮证券研究员盛丽华发布了对迈威生物的研报《商业化提速,Nectin-4 ADC迈入价值兑现关键期》,该研报对迈威生物给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为49.49%。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为中泰证券的祝嘉琦。迈威生物(688062)个股概况:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400032056.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02493","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680964207","title":"股市必读:迈威生物新发布《迈威生物关于召开2026年第三季度业绩说明会的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2680964207","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680964207?lang=zh_cn&edition=full","pubTime":"2026-11-02 02:46","pubTimestamp":1793558791,"startTime":"0","endTime":"0","summary":"截至2026年10月30日收盘,迈威生物报收于20.03元,下跌6.18%,换手率2.74%,成交量10.97万手,成交额2.27亿元。当日关注点交易信息汇总:10月30日主力资金净流出2969.99万元,占总成交额13.09%。公司公告汇总:迈威生物将于2026年11月9日14:00-15:00通过“价值在线”平台召开2026年第三季度业绩说明会。投资者可通过指定网址或微信扫描小程序码参与互动,会前提问截止时间为2026年11月9日。说明会结束后可通过平台查看召开情况及主要内容。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200000695.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02493","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679934292","title":"10月30日迈威生物跌6.18%,中航优选领航混合发起A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2679934292","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679934292?lang=zh_cn&edition=full","pubTime":"2026-10-30 16:53","pubTimestamp":1793350403,"startTime":"0","endTime":"0","summary":"证券之星消息,10月30日迈威生物跌6.18%创60日新低,收盘报20.03元,换手率2.74%,成交量10.97万手,成交额2.27亿元。根据2026基金Q3季报公募基金重仓股数据,重仓该股的公募基金共11家,其中持有数量最多的公募基金为中航基金的中航优选领航混合发起A。中航优选领航混合发起A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000041344.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193705526","title":"迈威生物-B(02493)定于11月9日举办2026年第三季度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=1193705526","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193705526?lang=zh_cn&edition=full","pubTime":"2026-10-29 20:25","pubTimestamp":1793276729,"startTime":"0","endTime":"0","summary":"迈威(上海)生物科技股份有限公司10月29日在香港联交所发布海外监管公告称,公司将于2026年11月9日14:00-15:00通过“价值在线”以网络互动方式召开2026年第三季度业绩说明会。公告显示,公司已于2026年10月29日在上海证券交易所网站披露2026年第三季度报告。本次说明会旨在帮助投资者进一步了解公司经营业绩及发展战略,并就投资者普遍关注的问题进行解答。说明会结束后,投资者可通过“价值在线”或“易董”App查看会议情况及主要内容。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679048334","title":"迈威生物:关于召开2026年第三季度业绩说明会的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2679048334","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679048334?lang=zh_cn&edition=full","pubTime":"2026-10-29 20:02","pubTimestamp":1793275320,"startTime":"0","endTime":"0","summary":" 证券日报网讯 10月29日,迈威生物发布公告称,公司计划于2026年11月9日14:00-15:00举行2026年第三季度业绩说明会。 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261029/c681256309.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261029/c681256309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["02493","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679403994","title":"迈威生物9月30日股东户数1.86万户,较上期增加0.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679403994","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679403994?lang=zh_cn&edition=full","pubTime":"2026-10-29 18:58","pubTimestamp":1793271480,"startTime":"0","endTime":"0","summary":"证券之星消息,近日迈威生物披露,截至2026年9月30日公司股东户数为1.86万户,较6月30日增加100.0户,增幅为0.54%。户均持股数量由上期的2.17万股减少至2.15万股,户均持股市值为58.24万元 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261029/c681253493.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261029/c681253493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["02493","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678616004","title":"迈威生物-B(02493)前三季度实现营业收入约6.21亿元 同比增长9.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678616004","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678616004?lang=zh_cn&edition=full","pubTime":"2026-10-28 19:13","pubTimestamp":1793186031,"startTime":"0","endTime":"0","summary":"智通财经APP讯,迈威生物-B 公布2026年前三季度业绩,营业收入约6.21亿元,同比增长9.77%;归属于上市公司股东的净亏损约6.78亿元,基本每股亏损1.6元。国内市场,2026年第三季度实现药品销售收入约1.23亿元,同比增长122.13%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1514402.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678461607","title":"迈威生物-B(02493.HK)前三季度实现营业收入约6.21亿元 同比增长9.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678461607","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678461607?lang=zh_cn&edition=full","pubTime":"2026-10-28 19:13","pubTimestamp":1793186031,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02493","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678465576","title":"迈威生物2026年前三季度净亏损6.78亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678465576","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678465576?lang=zh_cn&edition=full","pubTime":"2026-10-28 18:35","pubTimestamp":1793183700,"startTime":"0","endTime":"0","summary":"北京商报讯(记者王寅浩宋雨盈)10月28日,迈威生物发布2026年三季报,前三季度公司实现营业收入6.21亿元,同比增长9.77%;归属于上市公司股东的净亏损为6.78亿元,上年同期为亏损5.98亿元; ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261028/c681200178.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261028/c681200178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["02493","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678435457","title":"迈威生物:第三季度亏损扩大至1.57亿元 营收同比降33.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678435457","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678435457?lang=zh_cn&edition=full","pubTime":"2026-10-28 17:39","pubTimestamp":1793180340,"startTime":"0","endTime":"0","summary":"10月28日,迈威生物(688062)公布2026年三季报,公司营业收入为6.21亿元,同比上升9.8%;归母净利润自去年同期亏损5.98亿元变为亏损6.78亿元,亏损额进一步扩大;扣非归母净利润自去年同期亏损6.22亿元变为亏损6.83亿元,亏损额进一步扩大;经营现金流净额为-7.45亿元,同比下降622.9%;EPS(全面摊薄)为-1.5186元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610283912106294.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610283912106294.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677903107","title":"迈威生物(688062)10月23日主力资金净卖出680.54万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677903107","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677903107?lang=zh_cn&edition=full","pubTime":"2026-10-24 08:20","pubTimestamp":1792801207,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月23日收盘,迈威生物报收于22.82元,上涨4.73%,换手率4.17%,成交量9.61万手,成交额2.1亿元。近5日资金流向一览见下表:迈威生物融资融券信息显示,融资方面,当日融资买入872.98万元,融资偿还1185.03万元,融资净偿还312.05万元。迈威生物主营业务:研发、生产以及销售创新型药物和生物类似药,以高效创新研发和产业化能力为支撑,通过治疗用生物制品的市场推广和销售获得商业利润。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102400006897.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","02493","688062","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677459839","title":"港股异动 | 迈威生物-B(02493.HK)涨近3% 将于ESMO 2026大会上以口头报告形式报告9MW2821临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2677459839","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677459839?lang=zh_cn&edition=full","pubTime":"2026-10-23 14:57","pubTimestamp":1792738656,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676500213","title":"迈威生物将在2026年ESMO口头报告9MW2821三阴性乳腺癌II期临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2676500213","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676500213?lang=zh_cn&edition=full","pubTime":"2026-10-19 18:50","pubTimestamp":1792407000,"startTime":"0","endTime":"0","summary":"10月19日,迈威(上海)生物科技股份有限公司将于2026年10月23日至10月27日在西班牙马德里举行的2026年欧洲肿瘤内科学会(ESMO)大会上,以口头报告形式公布靶向Nectin-4ADC创新药9MW2821用于既 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261019/c680846796.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261019/c680846796.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK1161","02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189484390","title":"迈威生物-B拟在2026年ESMO大会口头报告9MW2821治疗三阴性乳腺癌II期临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1189484390","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189484390?lang=zh_cn&edition=full","pubTime":"2026-10-19 18:26","pubTimestamp":1792405571,"startTime":"0","endTime":"0","summary":"迈威(上海)生物科技股份有限公司10月19日公告称,公司将于2026年10月23日至10月27日在西班牙马德里举行的2026年欧洲肿瘤内科学会年会上,以口头报告形式公布靶向Nectin-4抗体偶联药物9MW2821用于既往接受过以拓扑异构酶I抑制剂为载荷ADC治疗的局部晚期或转移性三阴性乳腺癌患者II期临床研究结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mabwell.com","stockEarnings":[{"period":"1week","weight":-0.0433},{"period":"1month","weight":-0.1149},{"period":"3month","weight":-0.2238},{"period":"6month","weight":-0.3026},{"period":"1year","weight":-0.3839},{"period":"ytd","weight":-0.3839}],"compareEarnings":[{"period":"1week","weight":-0.0519},{"period":"1month","weight":-0.0525},{"period":"3month","weight":-0.1384},{"period":"6month","weight":-0.1248},{"period":"1year","weight":-0.1326},{"period":"ytd","weight":-0.1256}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"公司是一家全产业链布局的创新型生物制药公司,始终秉承“让创新从梦想变成现实”的愿景,践行“探索生命,惠及健康”的使命,通过源头创新,为患者提供疗效更好、可及性更强的生物创新药,满足全球未被满足的临床需求。公司主营业务为研发、生产以及销售创新型药物和生物类似药。公司主要产品为抗体、ADC药物和重组蛋白、小分子化学药等药物。公司荣誉:上海产业人才队伍建设工作“优秀案例奖”、澳洲会计师公会“认可雇主”、星耀榜“2021中国生物创新药最具成长性年度大奖”、中国医药人才品牌榜总榜及最具竞争力品牌等。","exchange":"SEHK","name":"迈威生物-B","nameEN":"MABWELL-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"迈威生物-B(02493)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供迈威生物-B(02493)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"迈威生物-B,02493,迈威生物-B股票,迈威生物-B股票老虎,迈威生物-B股票老虎国际,迈威生物-B行情,迈威生物-B股票行情,迈威生物-B股价,迈威生物-B股市,迈威生物-B股票价格,迈威生物-B股票交易,迈威生物-B股票购买,迈威生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"迈威生物-B(02493)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供迈威生物-B(02493)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}